{"version":"1.0","provider_name":"hollandbio","provider_url":"https:\/\/www.hollandbio.nl\/en\/","title":"'Betrek pati\u00ebntervaring bij keuze vergoeding medicijn' - hollandbio","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"pSLdNNnvm0\"><a href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/betrek-patientervaring-bij-keuze-vergoeding-medicijn\/\">&#8216;Betrek pati\u00ebntervaring bij keuze vergoeding medicijn&#8217;<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/betrek-patientervaring-bij-keuze-vergoeding-medicijn\/embed\/#?secret=pSLdNNnvm0\" width=\"600\" height=\"338\" title=\"&#8220;&#8216;Betrek pati\u00ebntervaring bij keuze vergoeding medicijn&#8217;&#8221; &#8212; hollandbio\" data-secret=\"pSLdNNnvm0\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.hollandbio.nl\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Gegevens uit de dagelijkse klinische praktijk en ervaringen van pati\u00ebnten moeten meer invloed krijgen op de keuze om geneesmiddelen al dan niet te vergoeden. Dat betoogt farmaceutisch onderzoeker Amr Makady in\u00a0zijn proefschrift. Beleidsmakers in de gezondheidszorg maken momenteel meestal gebruik van de uitkomsten van health technology assessments (HTA). Dat zijn gerandomiseerde klinische studies, met vooraf [&hellip;]","thumbnail_url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","thumbnail_width":1200,"thumbnail_height":675}